PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection

Petrovas, Constantinos, Casazza, Joseph P., Brenchley, Jason M., Price, David A., Gostick, Emma, Adams, William C., Precopio, Melissa L., Schacker, Timothy +3 more·2006·The Journal of Experimental Medicine

Cited by (889)

Items 401–500 of 889

  1. Relevance of studying T cell responses in SIV-infected rhesus macaques
    Laura E. Valentine, David I. Watkins · 2008 · Trends in Microbiology
  2. Enhanced Antiviral T Cell Function in the Absence of B7-H1 Is Insufficient To Prevent Persistence but Exacerbates Axonal Bystander Damage during Viral Encephalomyelitis
    Timothy W. Phares, Stephen A. Stohlman, David R. Hinton, Roscoe Atkinson, Cornelia C. Bergmann · 2010 · The Journal of Immunology
  3. Transcriptional and epigenetic regulation of PD-1 expression
    Zengde Chi, Yan Lü, Yinlong Yang, Bingqing Li, Peiyuan Lu · 2021 · Cellular and Molecular Life Sciences
  4. HBcAg induces PD-1 upregulation on CD4+T cells through activation of JNK, ERK and PI3K/AKT pathways in chronic hepatitis-B-infected patients
    Man Li, Xuehua Sun, Xiaojun Zhu, Shu-Gen Jin, Zhen-Jun Zeng, Zhenhua Zhou, Zhuo Yu, Yueqiu Gao · 2011 · Laboratory Investigation
  5. Respiratory syncytial virus infection is associated with an altered innate immunity and a heightened pro-inflammatory response in the lungs of preterm lambs
    Fatoumata Ba Sow, Jack M. Gallup, Subramaniam Krishnan, Andriani C. Patera, JoAnn Suzich, Mark R. Ackermann · 2011 · Respiratory Research
  6. Clinical applications of PD-1-based therapy: a focus on pembrolizumab (MK-3475) in the management of melanoma and other tumor types
    April K.S. Salama, Tara C. Gangadhar · 2015 · OncoTargets and Therapy
  7. Enhanced Induction of HIV-specific Cytotoxic T Lymphocytes by Dendritic Cell-targeted Delivery of SOCS-1 siRNA
    Sandesh Subramanya, Myriam A. Armant, Janelle R. Salkowitz, Alice M. Nyakeriga, Viraga Haridas, Maroof Hasan, Anju Bansal, Paul Goepfert, Katherine K. Wynn, Kristin Ladell et al. · 2010 · Molecular Therapy
  8. Increased Programmed Death-1 Molecule Expression in Cytomegalovirus Disease and Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
    Ghislaine M. Gallez-Hawkins, Lia Thao, Joycelynne Michelle Palmer, Andrew Dagis, Xiuli Li, Anne E. Franck, Bernard Tegtmeier, Simon Francis Lacey, Don J. Diamond, Stephen J. Forman et al. · 2009 · Transplantation and Cellular Therapy
  9. Antiretroviral Therapy Reduces the Magnitude and T Cell Receptor Repertoire Diversity of HIV-Specific T Cell Responses without Changing T Cell Clonotype Dominance
    Joseph A. Conrad, Ramesh K. Ramalingam, Coley B. Duncan, Rita M. Smith, Jie Wei, Louise D. Barnett, Brenna C. Simons, Shelly L. Lorey, Spyros A. Kalams · 2012 · Journal of Virology
  10. Simian Immunodeficiency Virus (SIV)-Specific CD8+T-Cell Responses in Vervet African Green Monkeys Chronically Infected with SIVagm
    Roland C. Zahn, Melisa D. Rett, Birgit Korioth-Schmitz, Yue Sun, Adam P. Buzby, Simoy C. Goldstein, Charles R. Brown, Russell A. Byrum, Gordon James Freeman, Norman L. Letvin et al. · 2008 · Journal of Virology
  11. Microbiome in human immunodeficiency virus infection
    Salas, January T., Chang, Theresa L. · 2014 · Clinics in Laboratory Medicine
  12. miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma
    Anup Singh Pathania, Philip Prathipati, Omalla Allan Olwenyi, Srinivas Prabhu Chava, Oghenetejiri V. Smith, Subash C. Gupta, Nagendra K. Chaturvedi, Siddappa N. Byrareddy, Donald W. Coulter, Kishore B. Challagundla · 2022 · Molecular Therapy — Oncolytics
  13. Absence of Vasoactive Intestinal Peptide Expression in Hematopoietic Cells Enhances Th1 Polarization and Antiviral Immunity in Mice
    Jian-Ming Li, Lauren T. Southerland, Mohammad S Hossain, Cynthia R. Giver, Ying Wang, Kasia A. Darlak, Wayne Bernard Harris, James A. Waschek, Edmund K. Waller · 2011 · The Journal of Immunology
  14. γδ T‐cell responses during HIV infection and antiretroviral therapy
    Jennifer A. Juno, Emily Marie Eriksson · 2019 · Clinical & Translational Immunology
  15. B and T Lymphocyte Attenuator Down-regulation by HIV-1 Depends on Type I Interferon and Contributes to T-Cell Hyperactivation
    Zhang, Zheng, Xu, Xiangsheng, Lu, Jiyun, Zhang, Shuye, Gu, Lanlan, Fu, Junliang, Jin, Lei, Li, Haiying, Zhao, Min, Zhang, Jiyuan et al. · 2011 · The Journal of Infectious Diseases
  16. Myocardial Ischemia and Reperfusion Leads to Transient CD8 Immune Deficiency and Accelerated Immunosenescence in CMV-Seropositive Patients
    Jedrzej Hoffmann, Evgeniya V. Shmeleva, Stephen E. Boag, Karel Fišer, Alan J. Bagnall, Santosh Murali, Ian Dimmick, Hanspeter Pircher, Carmen M. Martin-Ruiz, Mohaned Egred et al. · 2014 · Circulation Research
  17. TLR-mediated induction of negative regulatory ligands on dendritic cells
    Stefan Gröschel, Kisha Piggott, Augusto Vaglio, Wei Ma-Krupa, Karnail Singh, Jörg J. Goronzy, Cornelia M. Weyand · 2008 · Journal of Molecular Medicine
  18. Immune checkpoint inhibitors in infectious disease
    Hannah A. D. King, Sharon R. Lewin · 2024 · Immunological Reviews
  19. 5th International Workshop on CMV and Immunosenescence ‐ A shadow of cytomegalovirus infection on immunological memory
    Ramon Arens, Ester B. M. Remmerswaal, Jos A. Bosch, René A. W. van Lier · 2015 · European Journal of Immunology
  20. Optimal Maturation of the SIV-Specific CD8+ T Cell Response after Primary Infection Is Associated with Natural Control of SIV: ANRS SIC Study
    Caroline Passaes, Antoine Millet, Vincent Madelain, Valérie Monceaux, Annie David, Pierre Versmisse, Naya Sylla, Emma Gostick D, Sian Llewellyn‐Lacey, David A. Price et al. · 2020 · Cell Reports
  21. Presence of Suppressor HIV-Specific CD8+ T Cells Is Associated with Increased PD-1 Expression on Effector CD8+ T Cells
    Mohamed Elrefaei, Chris A. R. Baker, Norman G. Jones, David R. Bangsberg, Huyen Cao · 2008 · The Journal of Immunology
  22. Impact of changes in antigen level on CD38/PD‐1 co‐expression on HIV‐specific CD8 T cells in chronic, untreated HIV‐1 infection
    Thomas Vollbrecht, Heike Brackmann, Nadja Henrich, Joerg Roeling, Ulrich Seybold, Johannes Richard Bogner, Frank Detlef Goebel, Rika Draenert · 2010 · Journal of Medical Virology
  23. Dominant Clonotypes within HIV-Specific T Cell Responses Are Programmed Death-1high and CD127low and Display Reduced Variant Cross-Reactivity
    Joseph A. Conrad, Ramesh K. Ramalingam, Rita M. Smith, Louise D. Barnett, Shelly L. Lorey, Jie Wei, Brenna C. Simons, Shanmugalakshmi Sadagopal, Dirk Meyer‐Olson, Spyros A. Kalams · 2011 · The Journal of Immunology
  24. Mucosal T‐cell responses to HIV: responding at the front lines
    Barbara L. Shacklett, J. William Critchfield, April L. Ferre, T. L. Hayes · 2008 · Journal of Internal Medicine
  25. Distinct SIV-specific CD8+ T cells in the lymph node exhibit simultaneous effector and stem-like profiles and are associated with limited SIV persistence
    Zachary Strongin, Laurence Raymond Marchand, Claire Deléage, María Betina Pampena, Maria Andrea Cardenas, Christian Michel Beusch, Timothy N. Hoang, Elizabeth Urban, Maël Gourvès, Kevin Nguyen et al. · 2024 · Nature Immunology
  26. Lymph node architecture collapse and consequent modulation of FOXO3a pathway on memory T- and B-cells during HIV infection
    Julien van Grevenynghe, Rabih Halwani, Nicolas Chomont, Petronela Ancuța, Yoav Peretz, André Tanel, Francesco A. Procopio, Yu shi, Elias Anthony Said, Elias K. Haddad et al. · 2008 · Seminars in Immunology
  27. PD-1/PD-L1 Blockade Can Enhance HIV-1 Gag-specific T Cell Immunity Elicited by Dendritic Cell-Directed Lentiviral Vaccines
    Bingbing Dai, Xiao Liang, Paul D. Bryson, Jinxu Fang, Pin Wang · 2012 · Molecular Therapy
  28. The Role of Immunomodulatory Receptors in the Pathogenesis of HIV Infection: A Therapeutic Opportunity for HIV Cure?
    Hui Chen, Maha Moussa, Marta Catálfamo · 2020 · Frontiers in Immunology
  29. CD4+ and CD8+ T Cells Expressing FoxP3 in HIV-Infected Patients Are Phenotypically Distinct and Influenced by Disease Severity and Antiretroviral Therapy
    Andrew Y. F. Lim, Martyn A. French, Patricia Price · 2009 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  30. HTLV-1 Tax Specific CD8+ T Cells Express Low Levels of Tim-3 in HTLV-1 Infection: Implications for Progression to Neurological Complications
    Lishomwa C. Ndhlovu, Fábio E. Leal, Aaron M. Hasenkrug, Aashish R. Jha, Karina Inacio Carvalho, Ijeoma G. Eccles-James, Fernanda Romano Bruno, Raphaella G. S. Vieira, Vanessa A. York, Glen M. Chew et al. · 2011 · PLoS neglected tropical diseases
  31. Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck
    Anna D. Kosinska, Jia Liu, Mengji Lu, Michael Roggendorf · 2014 · Medical Microbiology and Immunology
  32. PD-1 Expression and Cytokine Secretion Profiles of Mycobacterium tuberculosis-Specific CD4+ T-Cell Subsets; Potential Correlates of Containment in HIV-TB Co-Infection
    Katrina M. Pollock, Damien Montamat‐Sicotte, Lisa Grass, Graham Cooke, Moses Silungwe Kapembwa, Onn Min Kon, Robert D. Sampson, Graham Philip Taylor, Ajit Lalvani · 2016 · PLoS ONE
  33. Disruption of the γc cytokine network in T cells during HIV infection
    Danylo Sirskyj, Jacques Thèze, Ashok Kumar, Marko Kryworuchko · 2008 · Cytokine
  34. Peripheral tolerance in CD8+ T cells
    Mathangi Srinivasan, Kenneth A. Frauwirth · 2009 · Cytokine
  35. Novel strategies to eliminate persistent viral infections
    Marianne M. A. Martinic, Matthias G. von Herrath · 2008 · Trends in Immunology
  36. Sicilian semi- and supercentenarians: identification of age-related T-cell immunophenotype to define longevity trait
    Mattia Emanuela Ligotti, Giulia Accardi, Anna Aiello, Stefano Aprile, Anna Calabrò, Rosalia Caldarella, Calogero Caruso, Marcello Ciaccio, Anna Maria Corsale, Francesco Dieli et al. · 2023 · Clinical & Experimental Immunology
  37. Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients
    Amanda L. Gill, Samantha A. Green, Shahed Azzam Ahmed Abdullah, Cécile Le Saout, Stefania Pittaluga, Hui Chen, Refika Turnier, Jeffrey D. Lifson, Steven Godin, Jing Qin et al. · 2016 · AIDS
  38. Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection
    Jeffrey E. Teigler, Gennadiy Zelinskyy, Michael A. Eller, Diane L. Bolton, Mary Marovich, Alexander D. Gordon, Aljawharah Alrubayyi, Galit Alter, Merlin Lee Robb, Jeffrey N. Martin et al. · 2017 · Journal of Virology
  39. Immune Checkpoint Blockade in Breast Cancer Therapy
    Xia Bu, Yihui Yao, Xiaoyü Li · 2017 · Advances in experimental medicine and biology
  40. Dendritic cell-based cancer immunotherapy in the era of immune checkpoint inhibitors: From bench to bedside
    Farid Ghorbaninezhad, Zahra Asadzadeh, Javad Masoumi, Ahad Mokhtarzadeh, Tohid Kazemi, Leili Aghebati Maleki, Siamak Sandoghchian Shotorbani, Mahdi Abdoli Shadbad, Amir Baghbanzadeh, Nima Hemmat et al. · 2022 · Life Sciences
  41. Beyond adjuvants: Immunomodulation strategies to enhance T cell immunity
    Alice Oliffson Kamphorst, Koichi Araki, Rafi Ahmed · 2015 · Vaccine
  42. Tumor necrosis factor-alpha blockage therapy impairs hepatitis B viral clearance and enhances T-cell exhaustion in a mouse model
    I. Chyuan, Hwei-Fang Tsai, Horng-Tay Tzeng, Chi-Chang Sung, C. Wu, Pei-Jer Chen, P. Hsu · 2015 · Cellular & Molecular Immunology
  43. The road to recovery: translating PD-1 biology into clinical benefit
    James L. Riley, Carl H. June · 2006 · Trends in Immunology
  44. Programmed Death-1 Expression on Epstein Barr Virus Specific CD8+ T Cells Varies by Stage of Infection, Epitope Specificity, and T-Cell Receptor Usage
    Thomas C. Greenough, Shalyn C. Campellone, Robin Brody, Surbhi Jain, Víctor Sánchez-Merino, Mohan Somasundaran, Katherine Luzuriaga · 2010 · PLoS ONE
  45. Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir
    James L. Riley, Luis J. Montaner · 2017 · The Journal of Infectious Diseases
  46. Nivolumab + Ipilimumab for patients with hepatocellular carcinoma previously treated with Sorafenib
    Josephine Tsang, Jeffrey Sum Lung Wong, Gin Wai Kwok, Bryan Cho Wing Li, Roland Ching-Yu Leung, Joanne Wing Yan Chiu, Tan To Cheung, Thomas C. C. Yau · 2021 · Expert Review of Gastroenterology & Hepatology
  47. Human Immunodeficiency Virus Infection Promotes Human Papillomavirus-Mediated Anal Squamous Carcinogenesis: An Immunologic and Pathobiologic Review
    Omar Bushara, Katrina Krogh, Samuel Edward Weinberg, Brian Steven Finkelman, Leyu Sun, Jie Liao, Guang‐Yu Yang · 2021 · Pathobiology
  48. The Clonal Expansion Dynamics of the HIV-1 Reservoir: Mechanisms of Integration Site-Dependent Proliferation and HIV-1 Persistence
    Yang-Hui Jimmy Yeh, Kerui Yang, Anya Razmi, Ya‐Chi Ho · 2021 · Viruses
  49. Expansion of Dysfunctional Tim-3–Expressing Effector Memory CD8+ T Cells during Simian Immunodeficiency Virus Infection in Rhesus Macaques
    Tsuyoshi Fujita, Benjamin J. Burwitz, Glen M. Chew, Jason S. Reed, Reesab Pathak, Elizabeth Seger, Kiera Clayton, James M. Rini, Mario Ostrowski, Naoto Ishii et al. · 2014 · The Journal of Immunology
  50. TLR-9 signaling and TCR stimulation co-regulate CD8+ T cell-associated PD-1 expression
    Raymond M.H. Wong, Kent A. Smith, Victor L. Tam, Robb R. Pagarigan, Brenna L. Meisenburg, Angeline M. Quach, Mayra A. Carrillo, Zhiyong Qiu, Adrian I Bot · 2009 · Immunology Letters
  51. Impact of highly active antiretroviral therapy initiation on CD4+ T-cell repopulation in duodenal and rectal mucosa
    Timothy L. Hayes, David M. Asmuth, J. William Critchfield, Thomas H. Knight, Bridget E. McLaughlin, Tammy Yotter, Delandy H. McConnell, Juan Carlos Garcia, Richard B. Pollard, Barbara L. Shacklett · 2012 · AIDS
  52. Programmed Cell Death-1 Receptor (PD-1)-Mediated Regulation of Innate Lymphoid Cells
    Grace Mallett, Arian D. J. Laurence, Shoba Amarnath · 2019 · International Journal of Molecular Sciences
  53. HIV-1 Tat affects the programming and functionality of human CD8+ T cells by modulating the expression of T-box transcription factors
    Fabio Sforza, Francesco Nicoli, Eleonora Gallerani, Valentina Finessi, Eva Reali, Aurelio Cafaro, Antonella Caputo, Barbara Ensoli, Riccardo Gavioli · 2014 · AIDS
  54. Terminal Effector CD8 T Cells Defined by an IKZF2+IL-7R− Transcriptional Signature Express FcγRIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular Cytotoxicity
    Prossy Naluyima, Kerri G. Lal, Margaret C. Costanzo, Gustavo H. Kijak, Veronica D. Gonzalez, Kim G. Blom, Leigh Anne Eller, Matthew Creegan, Ting Hong, Dohoon Kim et al. · 2019 · The Journal of Immunology
  55. PD-1 Expression on NK Cells in Malaria-Exposed Individuals Is Associated with Diminished Natural Cytotoxicity and Enhanced Antibody-Dependent Cellular Cytotoxicity
    Jacqueline Moebius, Rajan Guha, Mary Peterson, Kaveh Abdi, Jeff Skinner, Shanping Li, Gunjan Arora, Boubacar Traoré, Sumati Rajagopalan, Eric O. Long et al. · 2020 · Infection and Immunity
  56. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics
    Vinayaka Kotraiah, Timothy W. Phares, Cecille D. Browne, James Pannucci, Marc Mansour, Amy R. Noe, Kenneth D. Tucker, Jayne M. Christen, Charles Reed, Alecia MacKay et al. · 2020 · Frontiers in Immunology
  57. Fungal Infections Potentiated by Biologics
    Matthew R Davis, George R. Thompson, Thomas F. Patterson · 2020 · Infectious Disease Clinics of North America
  58. Epigenetic Features of HIV-Induced T-Cell Exhaustion Persist Despite Early Antiretroviral Therapy
    Genevieve Elizabeth Martin, Debattama R. Sen, Matthew J. Pace, Nicola Robinson, Jodi Meyerowitz, Emily Adland, John Patrick Thornhill, Mathew Jones, Ane Ogbe, Lucia Parolini et al. · 2021 · Frontiers in Immunology
  59. Immunotherapy for Bone and Soft Tissue Sarcomas
    Takenori Uehara, Tomohiro Fujiwara, Ken Takeda, Toshiyuki Kunisada, Toshifumi Ozaki, Heiichiro Udono · 2015 · BioMed Research International
  60. Foxo3a: An integrator of immune dysfunction during HIV infection
    Julien van Grevenynghe, Rafael A. Cubas, Sandrina DaFonseca, Talibah U. Metcalf, Cecile L. Tremblay, Lydie Trautmann, Rafick‐Pierre Sékaly, John D. Schatzle, Elias K. Haddad · 2012 · Cytokine & Growth Factor Reviews
  61. A suspenseful game of 'hide and seek' between virus and host
    Michael B. A. Oldstone · 2007 · Nature Immunology
  62. Programmed death-1 expression is associated with the disease status in hepatitis B virus infection
    Pian Ye, Zhihong Weng, Shuling Zhang, Jian-Ao Zhang, Lei Zhao, Ji-Hua Dong, Shenghua Jie, Ran Pang, Rong-Hua Wei · 2008 · World Journal of Gastroenterology
  63. Transcriptional Signals of T-cell and Corticosteroid-sensitive Genes Are Associated With Future Acute Cellular Rejection in Cardiac Allografts
    Mandeep R. Mehra, JON A. KOBASHIGAWA, Mario C.-H.K. Deng, Kenneth C. Fang, Tod M. Klingler, Preeti G. Lal, Steven J. Rosenberg, Patricia A. Uber, Randall C. Starling, Srinivas Murali et al. · 2007 · The Journal of Heart and Lung Transplantation
  64. Functional Tolerance of CD8+ T Cells Induced by Muscle-Specific Antigen Expression
    Sébastien Calbo, Héloïse M Delagreverie, Christophe Arnoult, François‐Jérôme Authier, François Tron, Olivier Boyer · 2008 · The Journal of Immunology
  65. The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection
    Michael Roggendorf, Anna D. Kosinska, Jia Liu, Mengji Lu · 2015 · Cold Spring Harbor Perspectives in Medicine
  66. Transcription factor BACH2 shapes tissue-resident memory T cell programs to promote HIV-1 persistence
    Yulong Wei, Haocong Katherine Ma, Michelle E. Wong, Hyein Back, Emmanouil Papasavvas, Karam Mounzer, Faten N. Aberra, Ricardo Morgenstern, Pablo Tebas, Liza Konnikova et al. · 2025 · Immunity
  67. Programmed death-1 receptor and interleukin-10 in liver transplant recipients at high risk for late cytomegalovirus disease
    Aparna Krishnan, Wendi Zhou, Simon Francis Lacey, Ajit P. Limaye, Don J. Diamond, Corinna La Rosa · 2010 · Transplant Infectious Disease
  68. PD-1 Predicts CD4 Loss Rate in Chronic HIV-1 Infection Better Than HIV RNA and CD38 But Not in Cryopreserved Samples
    Dag Kvale, Malin Holm Meyer‐Myklestad, Frank Olav Pettersen · 2008 · Current HIV Research
  69. COVID-19: The Emerging Immunopathological Determinants for Recovery or Death
    Tanveer Ahmad, Rituparna Chaudhuri, Mohan Chandra Joshi, Ahmad Almatroudi, Arshad Husain Rahmani, Syed Mansoor Ali · 2020 · Frontiers in Microbiology
  70. HIV-1-Specific CAR-T Cells With Cell-Intrinsic PD-1 Checkpoint Blockade Enhance Anti-HIV Efficacy in vivo
    Zhengtao Jiang, Huitong Liang, Hanyu Pan, Liang Yue, Hua Wang, Xinyi Yang, Panpan Lu, Xiao Zhang, Jinlong Yang, Dengji Zhang et al. · 2021 · Frontiers in Microbiology
  71. Cutting Edge: Programmed Death-1 Up-Regulation Is Involved in the Attrition of Cytomegalovirus-Specific CD8+ T Cells in Acute Self-Limited Hepatitis B Virus Infection
    Ji‐Yuan Zhang, Zheng Zhang, Bo Jin, Shuye Zhang, Chun‐Bao Zhou, Junliang Fu, Fu‐Sheng Wang · 2008 · The Journal of Immunology
  72. Suppression of HIV Replication by Antiretroviral Therapy Reduces TIM-3 Expression on HIV-Specific CD8 + T Cells
    Afework Kassu, Roland A. Marcus, Michelle D’Souza, Elizabeth A. Kelly-McKnight, Brent E. Palmer · 2010 · AIDS Research and Human Retroviruses
  73. The Duration of Exposure to HIV Modulates the Breadth and the Magnitude of HIV-Specific Memory CD4+ T Cells
    Souheil‐Antoine Younes, Lydie Trautmann, Bader Yassine‐Diab, Lena H. Kalfayan, Anne‐Elen Kernaleguen, Thomas O. Cameron, R Boulassel, Lawrence J. Stern, Jean‐Pierre Routy, Zvi Grossman et al. · 2007 · The Journal of Immunology
  74. siRNA Knockdown of PD-L1 and PD-L2 in Monocyte-Derived Dendritic Cells only Modestly Improves Proliferative Responses to Gag by CD8+ T Cells from HIV-1-Infected Individuals
    Gaëlle Breton, Bader Yassine‐Diab, Lillian B. Cohn, Mohamed Rachid Boulassel, Jean‐Pierre Routy, Rafick‐Pierre Sékaly, Ralph M. Steinman · 2009 · Journal of Clinical Immunology
  75. B and T lymphocyte attenuator is highly expressed on intrahepatic T cells during chronic HBV infection and regulates their function
    Cai, Gang, Nie, Xiaomeng, Li, Lei, Hu, Liang, Wu, Beiying, Lin, Jiafei, Jiang, Cen, Wang, Huaizhou, Wang, Xuefeng, Shen, Qian · 2013 · Journal of Gastroenterology
  76. The Role of Caveolin 1 in HIV Infection and Pathogenesis
    Ayalew Mergia · 2017 · Viruses
  77. The Tumor Microenvironment in Post-Transplant Lymphoproliferative Disorders
    Lukas Marcelis, Thomas Tousseyn · 2019 · Cancer Microenvironment
  78. Elevated expression of miR-146a correlates with high levels of immune cell exhaustion markers and suppresses cellular immune function in chronic HIV-1-infected patients
    Ting Yu, Zhao Ju, Mingqi Luo, Rong‐Hua Hu, Yan Teng, Linlin Xie, Chaojie Zhong, Lang Chen, Wei Hou, Yong Xiong et al. · 2019 · Scientific Reports
  79. Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C
    Sylwia Osuch, Tomasz Laskus, Hanna Berak, Karol Perlejewski, Karin Jutta Metzner, Marcin Paciorek, Marek Radkowski, Kamila Caraballo Cortés · 2020 · Scientific Reports
  80. Mapping the interplay between NK cells and HIV: therapeutic implications
    Renee R. Anderko, Robbie B. Mailliard · 2023 · Journal of Leukocyte Biology
  81. Inhibitory Signals Mediated by Programmed Death‐1 Are Involved With T‐Cell Function in Chronic Periodontitis
    Eduardo Aleixo Figueira, Maria Lúcia Rubo de Rezende, Sérgio Aparecido Torres, Gustavo Pompermaier Garlet, Vanessa Soares Lara, Carlos Ferreira Santos, Mário Júlio Ávila-Campos, João S. Silva, Ana Paula Campanelli · 2009 · Journal of Periodontology
  82. Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescencein situhybridization (FISH) to select the optimal patients for matched therapy?
    Young Kwang Chae, Ayush Arya, Lauren S. Chiec, Hiral Anil Shah, Ari Joseph Rosenberg, Sandip Pravin Patel, Kirtee Raparia, Jaehyuk Choi, Derek Alan Wainwright, Victoria Meucci Villaflor et al. · 2017 · Oncotarget
  83. In Vivo Persistence of Codominant Human CD8+ T Cell Clonotypes Is Not Limited by Replicative Senescence or Functional Alteration
    Laurent Derré, Marc Bruyninx, Petra Baumgaertner, Estelle Devêvre, Patricia Corthésy, Cédric Touvrey, Yolanda D. Mahnke, Hanspeter Pircher, Verena Voelter, Pedro J. Romero et al. · 2007 · The Journal of Immunology
  84. Dendritic Cells Matured by Inflammation Induce CD86-Dependent Priming of Naive CD8+ T Cells in the Absence of Their Cognate Peptide Antigen
    Asher Maroof, Lynette Beattie, Alun C. Kirby, Mark Christopher Coles, Paul Martin Kaye · 2009 · The Journal of Immunology
  85. Unique features of memory T cells in HIV elite controllers: a systems biology perspective
    Simone Gonçalves Fonseca, Francesco A. Procopio, Jean-Philippe Goulet, Bader Yassine‐Diab, Petronela Ancuța, Rafick‐Pierre Sékaly · 2011 · Current Opinion in HIV and AIDS
  86. Long-Term Programming of Antigen-Specific Immunity from Gene Expression Signatures in the PBMC of Rhesus Macaques Immunized with an SIV DNA Vaccine
    Sarah E. Belisle, Jiangmei Yin, Devon J. Shedlock, Anlan Dai, Jian Yan, Lauren A. Hirao, Michele A. Kutzler, Mark G. Lewis, Hanné Andersen, Simon M. Lank et al. · 2011 · PLoS ONE
  87. Expression of inhibitory markers is increased on effector memory T cells during hepatitis C virus/HIV coinfection as compared to hepatitis C virus or HIV monoinfection
    Banishree Saha, Manish Chandra Choudhary, Shiv Kumar Sarin · 2013 · AIDS
  88. Dendritic cells at the interface of innate and adaptive immunity to HIV-1
    Anna Smed‐Sörensen, Karin Loré · 2011 · Current Opinion in HIV and AIDS
  89. A Role of Intracellular Toll-Like Receptors (3, 7, and 9) in Response to Mycobacterium tuberculosis and Co-Infection with HIV
    Nguyễn Đức Huy, Nicky Gazy, Vishwanath Venketaraman · 2020 · International Journal of Molecular Sciences
  90. PD-1 blockade following ART interruption enhances control of pathogenic SIV in rhesus macaques
    Vijayakumar Velu, Kehmia Titanji, Hasan Ahmed, Ravi Dyavar Shetty, Lakshmi S. Chennareddi, Gordon James Freeman, Rafi Ahmed, Rama Rao Amara · 2022 · Proceedings of the National Academy of Sciences
  91. CAR T-cells to treat brain tumors
    Grace Guzman, Karolina Pellot, Megan R. Reed, Analiz Rodriguez · 2023 · Brain Research Bulletin
  92. Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions
    Tatiana M. García-Bates, Mariana L. Palma, Chengli Shen, Andrea A. Gambotto, Bernard J. C. Macatangay, Robert Louis Ferris, Charles R. Rinaldo, Robbie B. Mailliard · 2018 · Journal of Virology
  93. Translating insights from persistent LCMV infection into anti-HIV immunity
    Elizabeth B. Wilson, David G. Brooks · 2010 · Immunologic Research
  94. The woodchuck: A model for therapeutic vaccination against hepadnaviral infection
    Michael Roggendorf, Dongliang Yang, Mengji Lu · 2010 · Pathologie Biologie
  95. CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival
    Huazhen Liu, Feifei Qiu, Yuan-Zhong Wang, Qiaohuang Zeng, Cuihua Liu, Yuchao Chen, Chun-Ling Liang, Qunfang Zhang, Ling Han, Zhenhua Dai · 2019 · Frontiers in Immunology
  96. Human immunodeficiency virus (HIV-1) infection selectively downregulates PD-1 expression in infected cells and protects the cells from early apoptosis in vitro and in vivo
    Narasimhan J. Venkatachari, William G. Buchanan, Velpandi Ayyavoo · 2008 · Virology
  97. Targeting Sialidase to PD1 Enhances T cell Function and Tumor Control
    Brett M. Garabedian, Eleanor E. Bashian, Xiaoshuang Wang, Andrew J. Thompson, James C. Paulson · 2025 · ACS Central Science
  98. Memory T cells and their exhaustive differentiation in allograft tolerance and rejection
    Anna Valujskikh, X.C. Li · 2011 · Current Opinion in Organ Transplantation
  99. Differentiation of Antigen-Specific T Cells with Limited Functional Capacity during Mycobacterium tuberculosis Infection
    Yun Hee Jeong, Bo‐Young Jeon, Sun-Hwa Gu, Sang-Nae Cho, Sung Jae Shin, Jun Chang, Sang‐Jun Ha · 2013 · Infection and Immunity
  100. Immunosuppressive Mechanisms During Viral Infectious Diseases
    Ghanashyam Sarikonda, Matthias G. von Herrath · 2010 · Methods in molecular biology